Despite the fact that the magnetic hyperthermia (MH) has been known for more than 75
years, it is still debated in its clinical applications. The generation of a higher temperature at …

Hyperthermia, one of the oldest forms of cancer treatment involves selective heating of tumor
tissues to temperatures ranging between 39 and 45° C. Recent developments based on the …

Magnetic nanomaterials that respond to clinical magnetic devices have significant potential
as cancer nanotheranostics. The complexities of their physics, however, introduce …

Hyperthermia, the mild elevation of temperature to 40–43° C, can induce cancer cell death
and enhance the effects of radiotherapy and chemotherapy. However, achievement of its full …

Regions of low oxygenation (hypoxia) are a characteristic feature of solid tumors, and cells
existing in these regions are a major factor influencing radiation resistance as well as …

Hyperthermia, the procedure of raising the temperature of tumour-loaded tissue to 40–43° C,
is applied as an adjunctive therapy with various established cancer treatments such as …

In oncology, the term 'hyperthermia'refers to the treatment of malignant diseases by
administering heat in various ways. Hyperthermia is usually applied as an adjunct to an …

There is a clear rationale for using hyperthermia in cancer treatment. Treatment at
temperatures between 40 and 44° C is cytotoxic for cells in an environment with a low pO 2 …

The purpose of this article is to provide an overview on the current clinical application of
hyperthermia combined with conventional treatment modalities (eg ionizing radiation …

Purpose Randomized clinical trials have demonstrated hyperthermia (HT) enhances
radiation response. These trials, however, generally lacked rigorous thermal dose …